Mark Ziebell was present at the annual shareholder meeting. According to his bio on his firm's website:

Venture Capital, Fund Formation and Other Corporate Services

• Represented software company in connection with two rounds of venture capital financing
• Represented data center hardware manufacturer in connection with initial round of venture capital financing and subsequent debt financing
• Represented two retail food chains in connection with restructuring and buy-out of venture capital investors
• Represented biopharmaceuticals company in connection with $10 million loan facility
• Represented developer of cryogenic shipping devices in connection with private placement financing
• Represented microcap fund in connection with formation and raising of a $30 million fund

If you look at SEC filings for Peregrine Pharmaceuticals and Cryoport, Ziebell's name appears as does Carlton Johnson's which also means Swartz. Doesn't it make you wonder who is really calling the shots with PTSC? Is Swartz a de facto director who may be behind thwarting every shareholder attempt to have our nominee on the board of directors? Makes me really wonder if there are things they just don't want us to find out.

Dr. Falk was no more qualified to sit on the board than perhaps some of our very own shareholders. This board will spend our company money to pay attorneys like Ziebell to find a way to make sure that we never have representation. Why?

Is there a window of opportunity to nominate our candidates for director before May 31 when we change filing status to small filer which then will mean a three year wait. It seems to me that the change will be based on Nov 30, 2010 information, however, until that change takes place can we move to action now? anyone?